AI Biomed PredictionsIMRX – ASCO Data Will Decide Whether IMRX Earns Its Re-Rating ScanScor Admin / May 30, 2026
AI Biomed PredictionsACET – Midyear prula-cel data could redefine ACET’s autoimmune narrative ScanScor Admin / May 30, 2026
AI Biomed PredictionsCRDF – ASCO Data Could Decide Cardiff Oncology’s Next Sharp Repricing ScanScor Admin / May 28, 2026
AI Biomed PredictionsACHV – ACHV Faces Make-or-Break FDA Catalyst With Sharp Upside Potential ScanScor Admin / May 24, 2026
AI Biomed PredictionsAVIR – Phase 3 HCV data could decide Atea’s next rerating ScanScor Admin / May 20, 2026
AI Biomed PredictionsLXEO – Lexeo Nears Pivotal FDA Decision That Could Reprice Shares ScanScor Admin / May 20, 2026
AI Biomed PredictionsIRD – June science forum may reset Opus Genetics breakout narrative ScanScor Admin / May 20, 2026
AI Biomed PredictionsBNTC – Benitec’s next rerating likely hinges on FDA path clarity ScanScor Admin / May 20, 2026
AI Biomed PredictionsAUTL – Next Autolus rerating likely hinges on Q2 launch proof ScanScor Admin / May 20, 2026
AI Biomed PredictionsABEO – ZEVASKYN launch traction could force ABEO’s next sharp rerating ScanScor Admin / May 20, 2026
